The Columbia University Diabetes Research Center was established in May 2003. As the focus of diabetes research at the largest academic medical center in the largest U.S. metropolitan area, the Columbia DRC promotes interactions among an outstanding research base, integrating basic and translational diabetes research with existing institutional centers of excellence in obesity, atherosclerosis, neurobiology, and cardiovascular biology. The DRC fosters translation of basic research advances, clinical training, epidemiology, and-through its partnership with the Berrie Diabetes Center-encourages diabetes related philanthropy. The Biomedical Research Base is comprised of 84 NIH-, ADA- or JDRF-funded investigators at Columbia, and 7 at sister institutions in New York City. The DRC supports core facilities in (A) Genomics;(B) Hormone &Metabolite;(E) Histopathology;(F) Mouse Phenotyping;and (G) Flow Cytometry. Additionally, the DRC makes available funding for young investigators through a pilot/feasibility grant program (P&F), and provides established scientists in other research areas at Columbia University and in neighboring institutions with the opportunity and support to enter the diabetes field through this program. The DRC supports program enrichment activities, designed to increase the awareness of diabetes research in the scientific/academic community at Columbia University;it also promotes interactions with academic institutions in the greater New York area. An administrative Core provides overall logistical support, financial oversight and integration of research efforts, shared core facilities and P&F program administration. During the past funding cycle, the DRC has endeavored to advance NIDDK's mission in diabetes by: (I) raising awareness of and interest in advanced clinical and basic diabetes research at Columbia University and in New York City;(ii) enhancing training and other diabetes-related educational opportunities for students, fellows, academic and community-based physicians;(///) attracting new investigators to diabetes research;{iv) providing state-of-the-art core facilities to enhance research of DRC members and contribute to the development of innovative methods for diabetes research and care;(v) fostering a collegial academic environment to facilitate information exchange within the institution and with other DRCs;(w) providing impetus to translate basic science discoveries into clinical care and community initiatives to improve the health of people with diabetes;and (wV) leveraging NIDDK resources with local and national philanthropic and diabetes advocacy organizations to integrate and expand P&F grants, as well as training and educational programs.

Public Health Relevance

; The Columbia University Diabetes Research Center continues to facilitate interactions among investigators from different academic backgrounds, providing material and intellectual support for initiatives that broaden our understanding of the causes of diabetes, and improve treatment outcomes;and to underwrite the operation of technical facilities for data acquisition and analysis, training opportunities for young investigators and students, and seeding funds for highly potentially transformative research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK063608-11
Application #
8435053
Study Section
Special Emphasis Panel (ZDK1-GRB-S (O2))
Program Officer
Hyde, James F
Project Start
2003-05-01
Project End
2018-01-31
Budget Start
2013-03-15
Budget End
2014-01-31
Support Year
11
Fiscal Year
2013
Total Cost
$1,357,235
Indirect Cost
$457,587
Name
Columbia University (N.Y.)
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Kode, A; Mosialou, I; Manavalan, S J et al. (2016) FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia 30:1-13
Kim-Muller, Ja Young; Kim, Young Jung R; Fan, Jason et al. (2016) FoxO1 Deacetylation Decreases Fatty Acid Oxidation in β-Cells and Sustains Insulin Secretion in Diabetes. J Biol Chem 291:10162-72
Kuo, Taiyi; Kim-Muller, Ja Young; McGraw, Timothy E et al. (2016) Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction. J Biol Chem 291:9648-56
Lerea, Jaclyn S; Ring, Laurence E; Hassouna, Rim et al. (2016) Reducing Adiposity in a Critical Developmental Window Has Lasting Benefits in Mice. Endocrinology 157:666-78
Xuan, Shouhong; Sussel, Lori (2016) GATA4 and GATA6 regulate pancreatic endoderm identity through inhibition of hedgehog signaling. Development 143:780-6
Grijalva, Ambar; Xu, Xiaoyuan; Ferrante Jr, Anthony W (2016) Autophagy Is Dispensable for Macrophage-Mediated Lipid Homeostasis in Adipose Tissue. Diabetes 65:967-80
Juan De Solis, Alain; Baquero, Arian F; Bennett, Camdin M et al. (2016) Postnatal undernutrition delays a key step in the maturation of hypothalamic feeding circuits. Mol Metab 5:198-209
Madra, M; Zeltser, L M (2016) BDNF-Val66Met variant and adolescent stress interact to promote susceptibility to anorexic behavior in mice. Transl Psychiatry 6:e776
Kim-Muller, Ja Young; Fan, Jason; Kim, Young Jung R et al. (2016) Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice. Nat Commun 7:12631
Li, Dylan; Zhang, Feng; Zhang, Xuan et al. (2016) Distinct functions of PPARγ isoforms in regulating adipocyte plasticity. Biochem Biophys Res Commun 481:132-138

Showing the most recent 10 out of 192 publications